Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zahrieh

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Contemporary Clinical Trials Communications|July 28, 2020
Sample size planning in the design and analysis of cluster randomized trials using the symbolic two-step methodDavid Zahrieh, Jennifer Le-Rademacher
Contemporary Clinical Trials|January 20, 2022
Symbolic two-step method compared with single-step methods to model the center-mean outcome in cluster randomized trialsDavid Zahrieh, Blaize W Kandler, Jennifer Le-Rademacher
Spatial and Spatio-Temporal Epidemiology|May 27, 2019
Quantifying geographic regions of excess stillbirth risk in the presence of spatial and spatio-temporal heterogeneityDavid Zahrieh, Jacob J Oleson, Paul A Romitti
Clinical Trials (London, England)|January 20, 2024
The symbolic two-step method applied to cancer care delivery research: Safeguarding against designing an underpowered cluster randomized trial with a continuous outcome by accounting for the imprecision in the within- and between-center variationDavid Zahrieh, Blaize W Kandler, Jennifer Le-Rademacher
Statistics in Medicine|January 27, 2009
A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival dataMarco Bonetti, David Zahrieh, Bernard F Cole, et al.
Contemporary Clinical Trials Communications|June 19, 2026
The design of a small Bayesian hybrid-controlled trial utilizing time-to-event data from six published sources that used best alternative care to treat liver-predominant metastasis from primary ocular melanomaDavid Zahrieh, Xiaofei Wang, Svetomir N Markovic, et al.
Blood|August 12, 2006
Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptideKatja Mauerer Zirlik, David Zahrieh, Donna Neuberg, et al.
BMJ Supportive & Palliative Care|November 1, 2018
Rose geranium in sesame oil nasal spray: a treatment for nasal vestibulitis?Elizabeth J Cathcart-Rake, Deanne Smith, David Zahrieh, et al.
Mayo Clinic Proceedings|November 3, 2023
Guidelines for Data and Safety Monitoring in Pragmatic Randomized Clinical Trials Using Case StudiesDavid Zahrieh, Ivana T Croghan, Jonathan W Inselman, et al.
Preventing Chronic Disease|March 11, 2021
Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease MappingDavid Zahrieh, Michael A Golafshar, Samir H Patel, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Contemporary Clinical Trials Communications|July 28, 2020
Sample size planning in the design and analysis of cluster randomized trials using the symbolic two-step methodDavid Zahrieh, Jennifer Le-Rademacher
Contemporary Clinical Trials|January 20, 2022
Symbolic two-step method compared with single-step methods to model the center-mean outcome in cluster randomized trialsDavid Zahrieh, Blaize W Kandler, Jennifer Le-Rademacher
Spatial and Spatio-Temporal Epidemiology|May 27, 2019
Quantifying geographic regions of excess stillbirth risk in the presence of spatial and spatio-temporal heterogeneityDavid Zahrieh, Jacob J Oleson, Paul A Romitti
Clinical Trials (London, England)|January 20, 2024
The symbolic two-step method applied to cancer care delivery research: Safeguarding against designing an underpowered cluster randomized trial with a continuous outcome by accounting for the imprecision in the within- and between-center variationDavid Zahrieh, Blaize W Kandler, Jennifer Le-Rademacher
Statistics in Medicine|January 27, 2009
A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival dataMarco Bonetti, David Zahrieh, Bernard F Cole, et al.
Contemporary Clinical Trials Communications|June 19, 2026
The design of a small Bayesian hybrid-controlled trial utilizing time-to-event data from six published sources that used best alternative care to treat liver-predominant metastasis from primary ocular melanomaDavid Zahrieh, Xiaofei Wang, Svetomir N Markovic, et al.
Blood|August 12, 2006
Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptideKatja Mauerer Zirlik, David Zahrieh, Donna Neuberg, et al.
BMJ Supportive & Palliative Care|November 1, 2018
Rose geranium in sesame oil nasal spray: a treatment for nasal vestibulitis?Elizabeth J Cathcart-Rake, Deanne Smith, David Zahrieh, et al.
Mayo Clinic Proceedings|November 3, 2023
Guidelines for Data and Safety Monitoring in Pragmatic Randomized Clinical Trials Using Case StudiesDavid Zahrieh, Ivana T Croghan, Jonathan W Inselman, et al.
Preventing Chronic Disease|March 11, 2021
Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease MappingDavid Zahrieh, Michael A Golafshar, Samir H Patel, et al.
Pageof 9